close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.66 +0.01 (+0.04%)
Official Closing Price Updated: 7:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
European Equities Soar to Six-Month Highs as Rate Cut Hopes and Sectoral Strength Drive Rally
The European stock market has concluded its strongest week in five to six months, with the pan-European STOXX 600 index climbing a significant 2.8% by the week ending October 3, 2025. This robust... 
Via MarketMinute
Topics Economy World Trade
Pfizer’s AI Revolution: A New Era for Drug Discovery and Pharmaceutical Innovation
In a groundbreaking strategic pivot, pharmaceutical giant Pfizer (NYSE: PFE) is aggressively integrating artificial intelligence (AI), machine learning (ML), and advanced data science across its entire... 
Via TokenRing AI
Topics Artificial Intelligence Economy
US Government Shutdown Casts Global Shadow: Economic Data Delays Fuel Investor Uncertainty
The United States government is currently in the throes of a shutdown, commencing at 12:01 a.m. EDT on October 1, 2025, after a congressional impasse prevented the passage of appropriations legislation... 
Via MarketMinute
Topics Bonds Economy Government
Gold Shines Bright: Seven-Week Rally Fueled by Government Shutdown and Economic Instability Fears
Gold prices have surged for an unprecedented seventh consecutive week, reaching near-record highs as of October 3, 2025. This remarkable rally, with spot gold trading between $3,859.69 and $3,885.73... 
Via MarketMinute
Topics Bonds Economy Government
Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In Markets
S&P500, Nasdaq100, Dow Jones, and Russell 2000 all hit record highs as investors focus on corporate optimism, monetary easing and AI tech. 
Via Benzinga
Topics Artificial Intelligence Stocks
Demystifying Pfizer: Insights From 4 Analyst Reviews
 
Via Benzinga
How Trump’s 100% Tariff Threat Forced Pfizer’s Hand — Inside The High-Stakes Talks That Changed Big Pharma’s Course
Via Stocktwits
Topics Government
A Look Into Pfizer Inc's Price Over Earnings
 
Via Benzinga
Data Blackout: Government Shutdown Leaves Fed Flying Blind Amidst Economic Crossroads
The U.S. economy finds itself at a critical juncture, navigating persistent inflation and a cooling labor market, while simultaneously grappling with the immediate and profound implications of an... 
Via MarketMinute
Topics Economy Energy Regulatory Compliance
Looking for the most active stocks in the S&P500 index on Friday?
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Friday and uncover the stocks that are leading the way in terms of trading volume and market... 
Via Chartmill
Bruker (BRKR) Stock Trades Up, Here Is Why
Shares of scientific instrument company Bruker (NASDAQ:BRKR). jumped 4.5% in the afternoon session after the company announced it had secured new orders worth approximately $10 million for its advanced... 
Via StockStory
Topics Government
Avantor (AVTR) Stock Is Up, What You Need To Know
Shares of life sciences company Avantor (NYSE:AVTR) jumped 4.9% in the afternoon session after sentiment towards the stock improved following a series of positive developments, including an analyst... 
Via StockStory
Topics Government
FTSE 100 Soars to New Heights Amidst Broad European Market Optimism
London's benchmark FTSE 100 index has repeatedly scaled fresh record highs in recent days, culminating in another historic close on October 1st and continuing its upward trajectory into October 3,... 
Via MarketMinute
Topics Artificial Intelligence Climate Change Economy
Why Shares of Eli Lilly Soared This Week
Pfizer's deal with the Trump administration raised hopes that Eli Lilly would also avoid pharmaceutical tariffs. 
Via The Motley Fool
Topics Government World Trade
Eli Lilly And Its Competitors Pop On The Pfizer News
Eli Lilly and other US-based drug makers have led the market over the last few days. 
Via Talk Markets
US Government Plunges into Shutdown: Markets Brace for Impact as Stalemate Continues
As of October 3, 2025, the United States federal government finds itself in the throes of a significant shutdown, marking the eleventh such occurrence in modern American history and the third under... 
Via MarketMinute
Topics Economy Government
These 3 Stocks Pay More Than 6%. Are Their Dividend Yields Too Good to Be True?
Dividend stocks can be great income-producing investments, but chasing high yields can sometimes leave you exposed to considerable risk. 
Via The Motley Fool
2 Reliable Dividend Stocks With Yields Above 6% That You Can Buy With $100 in October
You don't need to be rich to put your money to work on Wall Street. 
Via The Motley Fool
Topics Intellectual Property
Pfizer Just Made a Landmark Drug Pricing Agreement with President Donald Trump. Is the Stock a Buy?
The pharma giant just eliminated two big risks. 
Via The Motley Fool
Topics Government Intellectual Property World Trade
Federal Shutdown Paralysis: Data Delays Deepen Economic Damage Fears
The United States economy finds itself navigating treacherous waters as a federal government shutdown grips the nation, sparking heightened concerns about widespread economic damage. What makes this... 
Via MarketMinute
Topics Economy Initial Public Offering Regulatory Compliance
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
On October 2, 2025, the Healthcare sector emerged as a beacon of stability and growth within the S&P 500, delivering a robust positive performance that significantly contributed to the broader market's... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
Novo Nordisk (NVO) Soars as HSBC Upgrades to "Buy," Citing Strategic Focus and Pipeline Strength
Copenhagen, Denmark – October 2, 2025 – Shares of Danish pharmaceutical giant Novo Nordisk (NYSE: NVO) experienced a significant surge yesterday, October 1, 2025, following a pivotal upgrade from HSBC.... 
Via MarketMinute
Topics Economy
Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics Government World Trade
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics World Trade
These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap
Health care stocks are rallying, but Pfizer, Merck and Bristol-Myers still trade below 10x forward P/E — a rare market discount. 
Via Benzinga
FTSE 100 Stumbles: Commodity Crossroads for UK's Resource-Exposed Giants
London's benchmark FTSE 100 index experienced a slight retreat on October 2, 2025, closing down 0.23% at the end of a trading day that saw it touch new record highs before succumbing to a complex mix... 
Via MarketMinute
Topics Climate Change Derivatives Economy
Decoding Life's Blueprint: New Tech Maps RNA-Protein Interactions, Unlocking Disease Cures
A monumental leap in biomedical research has been announced with the development of a breakthrough technology capable of mapping the entire intricate network of RNA-protein interactions within human... 
Via MarketMinute
Topics Artificial Intelligence Derivatives
Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session.
Let's have a look at what is happening on the US markets on Thursday. Below you can find the most active S&P500 stocks in today's session. 
Via Chartmill
AstraZeneca Stock Is Up 10% on Tariff News. But Is the Pharmaceutical Giant a Buy?
The uncertainty about U.S. pharmaceutical tariffs shouldn't be as worrisome for AstraZeneca now. 
Via The Motley Fool
Topics Government World Trade
Why Charles River Laboratories (CRL) Stock Is Up Today
Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 1.9% in the morning session after Barclays upgraded the company to Overweight from Equal-Weight and raised its price target. 
Via StockStory
Topics Government
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today